Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.043x

Based on the latest financial reports, Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) has a cash flow conversion efficiency ratio of 0.043x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥1.73 Billion ≈ $253.37 Million USD) by net assets (CN¥39.98 Billion ≈ $5.85 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd - Cash Flow Conversion Efficiency Trend (2000–2024)

This chart illustrates how Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Guangzhou Baiyunshan Pharmaceutical Hold debt and liabilities for a breakdown of total debt and financial obligations.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
RLI Corp NYSE:RLI	0.101x
RTL GROUP UNSP.ADR 10 F:RRTU	N/A
Nanning Chemical Industry Co Ltd SHG:600301	0.065x
PennyMac Finl Svcs Inc NYSE:PFSI	-0.162x
OSI Systems Inc NASDAQ:OSIS	0.074x
Iljin Electric Co KO:103590	-0.143x
Laureate Education Inc NASDAQ:LAUR	0.126x
Charoen Pokphand Foods Public Company Limited BK:CPF	0.058x

Annual Cash Flow Conversion Efficiency for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (2000–2024)

The table below shows the annual cash flow conversion efficiency of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd from 2000 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Guangzhou Baiyunshan Pharmaceutical Hold.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥37.77 Billion ≈ $5.53 Billion	CN¥3.44 Billion ≈ $503.74 Million	0.091x	-18.54%
2023-12-31	CN¥36.68 Billion ≈ $5.37 Billion	CN¥4.10 Billion ≈ $600.49 Million	0.112x	-46.23%
2022-12-31	CN¥33.64 Billion ≈ $4.92 Billion	CN¥7.00 Billion ≈ $1.02 Billion	0.208x	+14.89%
2021-12-31	CN¥31.33 Billion ≈ $4.58 Billion	CN¥5.67 Billion ≈ $830.21 Million	0.181x	+772.92%
2020-12-31	CN¥28.21 Billion ≈ $4.13 Billion	CN¥585.19 Million ≈ $85.63 Million	0.021x	-89.26%
2019-12-31	CN¥25.99 Billion ≈ $3.80 Billion	CN¥5.02 Billion ≈ $734.93 Million	0.193x	-14.27%
2018-12-31	CN¥23.14 Billion ≈ $3.39 Billion	CN¥5.22 Billion ≈ $763.39 Million	0.225x	+136.80%
2017-12-31	CN¥19.26 Billion ≈ $2.82 Billion	CN¥1.83 Billion ≈ $268.33 Million	0.095x	-31.26%
2016-12-31	CN¥17.65 Billion ≈ $2.58 Billion	CN¥2.44 Billion ≈ $357.73 Million	0.138x	-38.08%
2015-12-31	CN¥8.68 Billion ≈ $1.27 Billion	CN¥1.94 Billion ≈ $284.17 Million	0.224x	+1.05%
2014-12-31	CN¥7.96 Billion ≈ $1.16 Billion	CN¥1.76 Billion ≈ $257.75 Million	0.221x	+16.05%
2013-12-31	CN¥7.02 Billion ≈ $1.03 Billion	CN¥1.34 Billion ≈ $195.96 Million	0.191x	+59.04%
2012-12-31	CN¥4.22 Billion ≈ $618.15 Million	CN¥506.53 Million ≈ $74.12 Million	0.120x	+359.40%
2011-12-31	CN¥3.90 Billion ≈ $569.99 Million	CN¥-180.05 Million ≈ $-26.35 Million	-0.046x	-330.06%
2010-12-31	CN¥3.64 Billion ≈ $532.87 Million	CN¥73.17 Million ≈ $10.71 Million	0.020x	-84.45%
2009-12-31	CN¥3.40 Billion ≈ $497.76 Million	CN¥439.39 Million ≈ $64.30 Million	0.129x	+6725.17%
2008-12-31	CN¥3.22 Billion ≈ $471.91 Million	CN¥6.10 Million ≈ $893.13K	0.002x	-98.34%
2007-12-31	CN¥3.29 Billion ≈ $482.05 Million	CN¥375.74 Million ≈ $54.98 Million	0.114x	+766.65%
2006-12-31	CN¥2.95 Billion ≈ $432.29 Million	CN¥38.88 Million ≈ $5.69 Million	0.013x	-74.75%
2005-12-31	CN¥2.81 Billion ≈ $410.74 Million	CN¥146.32 Million ≈ $21.41 Million	0.052x	-31.47%
2004-12-31	CN¥2.64 Billion ≈ $385.80 Million	CN¥200.54 Million ≈ $29.35 Million	0.076x	+2991.17%
2003-12-31	CN¥2.60 Billion ≈ $379.91 Million	CN¥-6.83 Million ≈ $-999.50K	-0.003x	-103.77%
2002-12-31	CN¥2.42 Billion ≈ $354.54 Million	CN¥169.01 Million ≈ $24.73 Million	0.070x	+13.67%
2001-12-31	CN¥2.28 Billion ≈ $334.18 Million	CN¥140.15 Million ≈ $20.51 Million	0.061x	-67.96%
2000-12-31	CN¥1.50 Billion ≈ $219.25 Million	CN¥286.95 Million ≈ $41.99 Million	0.192x	--

About Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

SHG:600332 China Medical Distribution

Market Cap

$4.66 Billion

CN¥31.84 Billion CNY

Market Cap Rank

#3757 Global

#603 in China

Share Price

CN¥22.65

Change (1 day)

-0.96%

52-Week Range

CN¥22.29 - CN¥27.59

All Time High

CN¥41.57